These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16556968)

  • 1. Potential inflammatory biomarkers in Alzheimer's disease.
    Mrak RE; Griffin WS
    J Alzheimers Dis; 2005 Mar; 8(4):369-75. PubMed ID: 16556968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis.
    Sheng JG; Ito K; Skinner RD; Mrak RE; Rovnaghi CR; Van Eldik LJ; Griffin WS
    Neurobiol Aging; 1996; 17(5):761-6. PubMed ID: 8892349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of chronic self-propagating glial responses in neurodegeneration: implications for long-lived survivors of human immunodeficiency virus.
    Mrak RE; Griffin WS
    J Neurovirol; 1997 Aug; 3(4):241-6. PubMed ID: 9291232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of cytokine IL-1α and S100β in different types of plaques in Alzheimer's disease].
    Yao JJ; He SR; Chen L; Yang L; Qiao XB; Zhang W; Du J; Liu DG
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):581-4. PubMed ID: 22177239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and neurodegenerative diseases.
    Griffin WS
    Am J Clin Nutr; 2006 Feb; 83(2):470S-474S. PubMed ID: 16470015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial cytokines in Alzheimer's disease: review and pathogenic implications.
    Mrak RE; Sheng JG; Griffin WS
    Hum Pathol; 1995 Aug; 26(8):816-23. PubMed ID: 7635444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury.
    Hayakata T; Shiozaki T; Tasaki O; Ikegawa H; Inoue Y; Toshiyuki F; Hosotubo H; Kieko F; Yamashita T; Tanaka H; Shimazu T; Sugimoto H
    Shock; 2004 Aug; 22(2):102-7. PubMed ID: 15257081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease.
    Darreh-Shori T; Vijayaraghavan S; Aeinehband S; Piehl F; Lindblom RP; Nilsson B; Ekdahl KN; Långström B; Almkvist O; Nordberg A
    Neurobiol Aging; 2013 Nov; 34(11):2465-81. PubMed ID: 23759148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble interleukin-1 receptor type II levels are elevated in cerebrospinal fluid in Alzheimer's disease patients.
    Garlind A; Brauner A; Höjeberg B; Basun H; Schultzberg M
    Brain Res; 1999 Apr; 826(1):112-6. PubMed ID: 10216202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution.
    Sheng JG; Mrak RE; Griffin WS
    Neuropathol Appl Neurobiol; 1995 Aug; 21(4):290-301. PubMed ID: 7494597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathology and the neuroinflammation idea.
    Mrak RE
    J Alzheimers Dis; 2009; 18(3):473-81. PubMed ID: 19584454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease.
    Mrak RE; Griffinbc WS
    Neurobiol Aging; 2001; 22(6):915-22. PubMed ID: 11754999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inflammatory pathway implication in pathogenesis of Alzheimer's disease].
    Liu DG
    Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):281-3. PubMed ID: 14518444
    [No Abstract]   [Full Text] [Related]  

  • 14. Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease.
    Peskind ER; Griffin WS; Akama KT; Raskind MA; Van Eldik LJ
    Neurochem Int; 2001; 39(5-6):409-13. PubMed ID: 11578776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain.
    Lee J; Chan SL; Mattson MP
    Neuromolecular Med; 2002; 2(1):29-45. PubMed ID: 12230303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions.
    Van Eldik LJ; Griffin WS
    Biochim Biophys Acta; 1994 Sep; 1223(3):398-403. PubMed ID: 7918676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pro-inflammatory cytokines in Alzheimer's disease].
    Stamouli EC; Politis AM
    Psychiatriki; 2016; 27(4):264-275. PubMed ID: 28114090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease.
    Pirttila T; Mehta PD; Frey H; Wisniewski HM
    Neurobiol Aging; 1994; 15(3):313-7. PubMed ID: 7936055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral cytokines, C-X-C motif ligand10 and interleukin-13, are associated with Malaysian Alzheimer's disease.
    Mohd Hasni DS; Lim SM; Chin AV; Tan MP; Poi PJH; Kamaruzzaman SB; Majeed ABA; Ramasamy K
    Geriatr Gerontol Int; 2017 May; 17(5):839-846. PubMed ID: 27215446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin.
    Lanzrein AS; Johnston CM; Perry VH; Jobst KA; King EM; Smith AD
    Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):215-27. PubMed ID: 9772027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.